Doxyhyklan 10% Side effects

• Side effects of Doxyhyklan 10% in details
• Doxyhyklan 10% contraindications
• Doxyhyklan 10% reviews

What are the possible side effects of Doxyhyklan 10%?

Get emergency medical help if you have any signs of an allergic reaction to Doxyhyklan 10%: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

• changes in your vision;

• severe stomach pain, diarrhea that is watery or bloody;

• fever, swollen glands, body aches, flu symptoms, weakness;

• skin rash, pale skin, easy bruising or bleeding, severe tingling, numbness, pain, muscle weakness;

• upper stomach pain (may spread to your back), loss of appetite, dark urine, jaundice (yellowing of the skin or eyes);

• chest pain, irregular heart rhythm, feeling short of breath;

• confusion, nausea and vomiting, swelling, rapid weight gain, little or no urinating;

• new or worsening cough with fever, trouble breathing;

• increased pressure inside the skull--severe headaches, ringing in your ears, dizziness, nausea, vision problems, pain behind your eyes; or

• severe skin reaction--fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.

Common Doxyhyklan 10% side effects may include:

• upset stomach;

• mild nausea, mild diarrhea;

• mild skin rash or itching; or

• vaginal itching or discharge.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Side effects of Doxyhyklan 10% in details

Clinical Trial Experience

The safety and efficacy of Doxyhyklan 10% Hyclate Delayed-Release Tablets, 200 mg as a single daily dose was evaluated in a multicenter, randomized, double-blind, active-controlled study. Doxyhyklan 10% Hyclate Delayed-Release Tablets 200 mg was given orally once-a-day for 7 days and compared to Doxyhyklan 10% hyclate capsules 100 mg given orally twice daily for 7 days for the treatment of men and women with uncomplicated urogenital C. trachomatis infection.

Adverse events in the Safety Population were reported by 99 (40.2%) subjects in the Doxyhyklan 10% Hyclate Delayed-Release Tablets, 200 mg treatment group and 132 (53.2%) subjects in the doxycyclinehyclate capsules reference treatment group. Most AEs were mild in intensity. The most commonly reported adverse events in both treatment groups were nausea, vomiting, diarrhea, and bacterial vaginitis, Table 1.

Table 1: Adverse Reactions Reported in Greater than or Equal to 2% of Subjects

	Doxyhyklan 10% Hyclate Delayed-Release Tablets, 200 mg N = 246
Preferred Term	n (%)
Subjects with any AE	99 (40.2)
Nausea	33 (13.4)
Vomiting	20 (8.1)
Headache	5 (2.0)
Diarrhea	8 (3.3)
Abdominal Pain Upper	5 (2.0)
Vaginitis Bacterial	8 (3.3)
Vulvovaginal Mycotic Infection	5 (2.0)

Because clinical trials are conducted under prescribed conditions, adverse reaction rates observed in the clinical trial may not always reflect the rates observed in practice.

Postmarketing Experience

The following adverse reactions have been identified during post-approval use of Doxyhyklan 10%. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate a causal relationship to drug exposure.

Due to oral Doxyhyklan 10%'s virtually complete absorption, side effects to the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines:

Gastrointestinal: Anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, and inflammatory lesions (with monilial overgrowth) in the anogenital region. Hepatotoxicity has been reported. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Esophagitis and esophageal ulcerations have been reported in patients receiving capsule and tablet forms of drugs in the tetracycline-class. Most of these patients took medications immediately before going to bed.

Skin: Maculopapular and erythematous rashes, Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, and erythema multiforme have been reported. Photosensitivity is discussed above.

Renal: Rise in BUN has been reported and is apparently dose-related.

Hypersensitivity reactions: Urticaria, angioneurotic edema, anaphylaxis, anaphylactoid purpura, serum sickness, pericarditis, and exacerbation of systemic lupus erythematosus.

Blood: Hemolytic anemia, thrombocytopenia, neutropenia, and eosinophilia have been reported.

Intracranial Hypertension: Intracranial hypertension (IH, pseudotumor cerebri) has been associated with the use of tetracycline

Thyroid Gland Changes: When given over prolonged periods, tetracyclines have been reported to produce brown-black microscopic discoloration of thyroid glands. No abnormalities of thyroid function are known to occur.

What is the most important information I should know about Doxyhyklan 10%?

• Hormonal birth control (eg, birth control pills) may not work as well while you are using Doxyhyklan 10% tablets. To prevent pregnancy, use an extra form of birth control (eg, condoms).
• Mild diarrhea is common with this type of medicine. However, a more serious form of diarrhea (pseudomembranous colitis) may rarely occur. This may develop while you use Doxyhyklan 10% tablets or within several months after you stop using it. Contact your doctor right away if stomach pain or cramps, severe diarrhea, or bloody stools occur. Do not treat diarrhea without first checking with your doctor.
• Long-term or repeated use of Doxyhyklan 10% tablets may cause a second infection. Tell your doctor if signs of a second infection occur. Your medicine may need to be changed to treat this.
• Doxyhyklan 10% tablets may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Doxyhyklan 10% tablets. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.
• Tell your doctor or dentist that you take Doxyhyklan 10% tablets before you receive any medical or dental care, emergency care, or surgery.
• Doxyhyklan 10% tablets may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Doxyhyklan 10% tablets.
• Lab tests, including liver function, kidney function, and complete blood counts, may be performed while you use Doxyhyklan 10% tablets. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
• Doxyhyklan 10% tablets should not be used in CHILDREN younger than 8 years old; permanent yellow-gray-brown tooth discoloration may occur.
• PREGNANCY and BREAST-FEEDING: Doxyhyklan 10% tablets has been shown to cause harm to the fetus. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Doxyhyklan 10% tablets while you are pregnant. Doxyhyklan 10% tablets is found in breast milk. Do not breast-feed while taking Doxyhyklan 10% tablets.

Doxyhyklan 10% contraindications

Do not use this medicine if you are pregnant. It could harm the unborn baby or cause permanent tooth discoloration later in life.

Doxyhyklan 10% can make birth control pills less effective. Ask your doctor about using a non hormone method of birth control (such as a condom, diaphragm, spermicide) to prevent pregnancy while using Doxyhyklan 10%.

You should not take this medicine if you are allergic to Doxyhyklan 10% or to other tetracycline antibiotics such as demeclocycline (Declomycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap).

Before taking Doxyhyklan 10%, tell your doctor if you have liver disease, kidney disease, asthma, or if you are allergic to sulfites.

Drink plenty of liquids while you are taking Doxyhyklan 10%.

Children should not use Doxyhyklan 10%. Doxyhyklan 10% can cause permanent yellowing or graying of the teeth in children younger than 8 years old.

Take this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics.

References

1. DailyMed. "DOXYCYCLINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. European Chemicals Agency - ECHA. "Doxycycline Hyclate: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
3. HSDB. "DOXYCYCLINE". https://toxnet.nlm.nih.gov/cgi-bin/s... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Doxyhyklan 10% are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Doxyhyklan 10%. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 8 here

Information checked by Dr. Sachin Kumar, MD Pharmacology